Intellia Therapeutics, Inc.
NasdaqGM:NTLA
$ 20.76
$0.00 (0.00%)
$ 20.76
$0.00 (0.00%)
End-of-day quote: 04/27/2024

NTLA - Intellia Therapeutics Stock Prediction 2025 - 2030

8 years of reliable Intellia Therapeutics stock forecast. The Wall Street analysts predict Outperform for NTLA. See at a glance whether NasdaqGM:NTLA will rise in the future.

$0.00
Forecast 2023
$24.83
Forecast 2025
$42.19
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$24.83
Forecast 2030
$42.19
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.8
Price-to-book Ratio
1.84
Market Cap
2.51B
TEV
1.61 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$75.84

Intellia Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Intellia Therapeutics Stock Forecast 2023

$70.00

In the last five quarters, Intellia Therapeutics’s Price Target has fallen from $125.88 to $75.84 - a -39.75% decrease. Twenty-four analysts predict that Intellia Therapeutics’s share price will fall in the coming year, reaching $70.00. This would represent a decrease of -7.7%.

237.19%
237.19
Last update: 04/27/2024

Highest Price Target $144.00

Average Price Target $70.00

Lowest Price Target $24.00

Intellia Therapeutics Stock Prediction 2025

Intellia Therapeutics Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $22.54. An increase of 8.55% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $22.74. An increase of 9.55% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $22.95. An increase of 10.56% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $23.16. An increase of 11.56% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $23.37. An increase of 12.56% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $23.58. An increase of 13.56% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $23.78. An increase of 14.57% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $23.99. An increase of 15.57% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $24.20. An increase of 16.57% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $24.41. An increase of 17.58% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $24.62. An increase of 18.58% compared to the previous month's estimate.

Intellia Therapeutics Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $24.83. An increase of 19.58% compared to the previous month's estimate.

Intellia Therapeutics Stock Forecast 2030

Stock Forecast for the Price of an Intellia Therapeutics Share in Jan 2030.

In January 2030, analysts believe the stock price will be $38.30. An increase of 84.48% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Feb 2030.

In February 2030, analysts believe the stock price will be $38.65. An increase of 86.19% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Mar 2030.

In March 2030, analysts believe the stock price will be $39.01. An increase of 87.89% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Apr 2030.

In April 2030, analysts believe the stock price will be $39.36. An increase of 89.6% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in May 2030.

In May 2030, analysts believe the stock price will be $39.71. An increase of 91.3% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Jun 2030.

In June 2030, analysts believe the stock price will be $40.07. An increase of 93.01% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Jul 2030.

In July 2030, analysts believe the stock price will be $40.42. An increase of 94.71% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Aug 2030.

In August 2030, analysts believe the stock price will be $40.78. An increase of 96.42% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Sep 2030.

In September 2030, analysts believe the stock price will be $41.13. An increase of 98.12% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Oct 2030.

In October 2030, analysts believe the stock price will be $41.48. An increase of 99.82% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Nov 2030.

In November 2030, analysts believe the stock price will be $41.84. An increase of 101.53% compared to the previous month's estimate.

Stock Forecast for the Price of an Intellia Therapeutics Share in Dec 2030.

In December 2030, analysts believe the stock price will be $42.19. An increase of 103.23% compared to the previous month's estimate.

P/E
0.00
Beta
1.8
Price-to-book Ratio
1.84
Market Cap
2.51B
TEV
1.61 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$75.84

Intellia Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Intellia Therapeutics, Inc.?

The following analysts have recently covered Intellia Therapeutics:

Baird
Barclays
BMO Capital Markets Equity Research
BofA Global Research
Brookline Capital Markets
Canaccord Genuity
Cantor Fitzgerald & Co.
Chardan Capital Markets, LLC
Citigroup Inc
Citigroup Inc. Research
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
J.P. Morgan
Jefferies LLC
JMP Securities
Leerink Partners LLC
Marktfeld
Morgan Stanley
Morningstar Inc.
Oppenheimer & Co. Inc.
Raymond James & Associates
RBC Capital Markets
Sanford C. Bernstein & Co., LLC
Stifel
TD Cowen
Truist Securities
Wedbush Securities Inc.
Wells Fargo Securities, LLC
William Blair & Company L.L.C.
Wolfe Research, LLC.
CGS International
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Intellia Therapeutics, Inc.?

The following sell-side analysts have recently covered Intellia Therapeutics:

Allen, Jack Kilgannon
Wang, Huidong
Biliouris, Konstantinos
Harrison, Gregory Allen
Cann, Leah Rush Vivian
Ijem, Whitney Glad
Bienkowski, Rick Stephen
Seedhouse, Steven James
Livshits, Yevgeniya
Lebowitz, David Neil
Bayko, Liisa Ann
Richter, Salveen Jaswal
Chattopadhyay, Debjit D.
Cheng, Lut Ming
Raycroft, Maurice Thomas
Tuerkcan, Silvan Can
Foroohar, Mani
Paraskevopoulos, Michail
Flynn, Terence C.
Elfman, Rachel
Olson, Jay
Issi, Luca
Pickering, William
Ha, Dae Gon
Thome, Joseph John-Charles
Lee, Joon So
Nierengarten, David Matthew
Zhu, Yanan
Minter, Myles Robert
Chen, Gao Yi
(This information refers to the last 90 days.)